SB 910 requires Maryland health insurers to reimburse patients for services provided by graduate-level clinical interns in counseling, social work, and psychology, under specific conditions. This affects insured individuals who receive these services and insurers who must cover them. Key conditions include services being provided at outpatient facilities, interns being enrolled in accredited graduate programs, working under direct supervision of a licensed professional, and billed by the supervising provider. The bill amends existing insurance codes (Sections 15-704, 15-707, and 15-714) to add these reimbursement requirements for each profession’s interns.
This bill expands Maryland's child abuse reporting requirements by explicitly including female genital mutilation in the legal definition of abuse, which directly affects healthcare providers, educators, and other mandated reporters. It mandates that these professionals report suspected cases of female genital mutilation to authorities and increases penalties for violations while allowing individuals subjected to the procedure to file civil lawsuits for relief. The legislation also requires the Maryland Department of Health to create and distribute educational materials about female genital mutilation in partnership with various public and private organizations. Additionally, the bill authorizes health licensing boards to revoke licenses of individuals who commit violations related to female genital mutilation under specific circumstances.
SB 562 allows pharmacists in Maryland to treat opioid use disorders using medication therapy under specific conditions. It repeals a requirement that prescribers (like doctors) must submit agreements to their health board and instead authorizes pharmacists to enter into prescriber-pharmacist agreements if they meet qualifications such as holding a Doctor of Pharmacy degree, completing required training, and registering with federal agencies. The law mandates that any treatment protocol requires pharmacists to check the Prescription Drug Monitoring Program before starting or changing medication. This change aims to expand access to medication-based treatment for opioid use disorders by enabling pharmacists to provide care in pharmacy settings.
SB 24 revises Maryland's Public Access Automated External Defibrillator (AED) Program to improve oversight and accessibility. It requires most organizations using public AEDs to appoint an AED coordinator responsible for maintenance, reporting, and emergency notification, while exempting law enforcement agencies from needing certificates for AEDs in patrol vehicles. The bill also repeals outdated requirements for regional AED committees and clarifies that grocery stores and restaurants are not subject to certain AED registration rules. These changes aim to streamline compliance for entities managing public AEDs, including schools, businesses, and public facilities.
HB 276 revises Maryland's Public Access Automated External Defibrillator (AED) Program to clarify requirements for entities using AEDs. It establishes a mandatory "AED Coordinator" role to maintain AED functionality and reporting, repeals outdated requirements for regional council AED committees, and exempts law enforcement agencies from needing a certificate for AEDs deployed in patrol vehicles. The bill affects businesses, organizations, and government entities that operate public AEDs, requiring them to maintain written AED plans and coordinate with emergency services. Key changes streamline oversight while ensuring AEDs remain accessible and properly maintained for public use during cardiac emergencies.
SB 14 adjusts when health coverage becomes effective for small businesses using Maryland's SHOP Exchange during specific special enrollment periods. It allows SHOP Exchanges to set coverage start dates based on when plan selections are received: the first day of the following month if received by the 15th, or the second month if received after the 15th. This applies to enrollments triggered by court-ordered dependents (like child support), death of an employee or dependent, or divorce/legal separation. The bill directly affects small employers and their employees/dependents who qualify for these special enrollment scenarios under Maryland's SHOP program. It takes effect October 1, 2026.
SB 139 amends Maryland law to strengthen oversight of third-party administrators (TPAs) who manage insurance claims for employers or insurers. It expands grounds for the Insurance Commissioner to deny, suspend, or revoke a TPA’s registration (including violations of insurance laws or regulations) and updates civil penalty rules. The bill sets a maximum $10,000 penalty per violation for TPA misconduct, with daily penalties up to $1,000 for ongoing violations. Penalties are determined based on factors like violation severity, the TPA’s history, and harm to policyholders, ensuring enforcement considers context and impact.
SB 134 requires Maryland insurance carriers to issue Medicare supplement policies (Medigap) to specific eligible individuals without denying coverage or charging higher premiums based on health status. It directly affects: (1) people transitioning from Maryland Medicaid to Medicare Part B, (2) individuals who became Medicare-eligible before January 2020, and (3) disabled people under 65 who qualify for Medicare. Key provisions mandate that carriers must sell these policies during defined 63-day enrollment periods following Medicaid disenrollment or qualifying events, and prohibit health-based pricing or denial for plans A and D. The law also requires carriers to offer comparable or lower-benefit plans during birthday renewals starting July 2026.
HB 278, the "Longevity Ready Maryland Act," requires Maryland's Secretary of Aging to lead implementation of the Longevity Ready Maryland Plan. This plan aims to coordinate state services for older adults by evaluating their needs, assessing existing programs, and fostering cross-sector collaboration across health, housing, employment, and social services. The bill mandates annual reports to the governor and legislature on progress, updates the Commission on Aging's role, and requires a comprehensive statewide plan to be revised every four years. It directly affects older Marylanders, the Department of Aging, local area agencies on aging, and state agencies responsible for aging-related services.
HB 236 extends the required blood testing window for combat sports athletes in Maryland from 30 days to 90 days. It affects boxers, kickboxers, wrestlers, and mixed martial arts competitors seeking licenses or participating in contests. The bill mandates that applicants and licensed contestants must provide documented evidence of negative tests for HIV, hepatitis B, and hepatitis C within 90 days prior to license application or competition. This change modifies existing Maryland law (Sections 4-101 and 4-304.1 of the Business Regulation Article) to align testing timing with the State Athletic Commission's requirements. The bill takes effect October 1, 2026.